GN, A., TZ, D., D, A., & MA, S. (2021). Expression of PD-L1 using SP142 CDx in triple negative breast cancer. Annals of diagnostic pathology, 51, 151703. https://doi.org/10.1016/j.anndiagpath.2021.151703
Chicago Style (17th ed.) CitationGN, Al-Jussani, Dabbagh TZ, Al-Rimawi D, and Sughayer MA. "Expression of PD-L1 Using SP142 CDx in Triple Negative Breast Cancer." Annals of Diagnostic Pathology 51 (2021): 151703. https://doi.org/10.1016/j.anndiagpath.2021.151703.
MLA (9th ed.) CitationGN, Al-Jussani, et al. "Expression of PD-L1 Using SP142 CDx in Triple Negative Breast Cancer." Annals of Diagnostic Pathology, vol. 51, 2021, p. 151703, https://doi.org/10.1016/j.anndiagpath.2021.151703.
Warning: These citations may not always be 100% accurate.